-
Electronic (PDF)
-
Site License
-
Enterprisewide
Hepatitis C Global Clinical Trials Review, H2, 2011
GlobalData, October 2011, Pages: 132
Hepatitis C Global Clinical Trials Review, H2, 2011
Summary
GlobalData's clinical trial report, “Hepatitis C Global Clinical Trials Review, H2, 2011" provides data on the Hepatitis C clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatitis C. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatitis C. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords
Hepatitis C Clinical Trials, Trial Designs, Trial Designs, Subjects Recruited, Unaccomplished Trials of Hepatitis C, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
List of Tables
List of Figures
Introduction
Hepatitis C
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Hepatitis C
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Hepatitis C Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
Abbott Laboratories
Clinical Trial Overview of Abbott Laboratories
Vertex Pharmaceuticals Incorporated
Clinical Trial Overview of Vertex Pharmaceuticals Incorporated
Gilead Sciences, Inc.
Clinical Trial Overview of Gilead Sciences, Inc.
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Novartis AG
Clinical Trial Overview of Novartis AG
Idenix Pharmaceuticals, Inc.
Clinical Trial Overview of Idenix Pharmaceuticals, Inc.
Tibotec Pharmaceuticals Ltd.
Clinical Trial Overview of Tibotec Pharmaceuticals Ltd.
Boehringer Ingelheim GmbH
Clinical Trial Overview of Boehringer Ingelheim GmbH
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Pharmasset, Inc
Clinical Trial Overview of Pharmasset, Inc
Mitsubishi Tanabe Pharma Corporation
Clinical Trial Overview of Mitsubishi Tanabe Pharma Corporation
Romark Laboratories, L.C.
Clinical Trial Overview of Romark Laboratories, L.C.
Hoffmann-La Roche Inc.
Clinical Trial Overview of Hoffmann-La Roche Inc.
Achillion Pharmaceuticals, Inc.
Clinical Trial Overview of Achillion Pharmaceuticals, Inc.
Human Genome Sciences, Inc.
Clinical Trial Overview of Human Genome Sciences, Inc.
UMC Utrecht
Clinical Trial Overview of UMC Utrecht
Clinical Trial Overview of Top Universities / Institutes / Hospitals
The National Institute of Allergy and Infectious Diseases
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
The National Institute of Diabetes and Digestive and Kidney Diseases
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases
French National Agency for Research on AIDS and Viral Hepatitis
Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis
University Health Network
Clinical Trial Overview of University Health Network
Kaohsiung Medical University Chung-Ho Memorial Hospital
Clinical Trial Overview of Kaohsiung Medical University Chung-Ho Memorial Hospital
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
U.S. Department of Veterans Affairs
Clinical Trial Overview of U.S. Department of Veterans Affairs
Hadassah Medical Organization
Clinical Trial Overview of Hadassah Medical Organization
Kyoto University
Clinical Trial Overview of Kyoto University
Okayama University
Clinical Trial Overview of Okayama University
Johns Hopkins University
Clinical Trial Overview of Johns Hopkins University
Henry Ford Health System
Clinical Trial Overview of Henry Ford Health System
University of Pittsburgh
Clinical Trial Overview of University of Pittsburgh
Rockefeller University
Clinical Trial Overview of Rockefeller University
McGill University Health Center
Clinical Trial Overview of McGill University Health Center
National Taiwan University Hospital
Clinical Trial Overview of National Taiwan University Hospital
Ziv Medical Center
Clinical Trial Overview of Ziv Medical Center
Cornell University
Clinical Trial Overview of Cornell University
Hospital Clinic de Barcelona
Clinical Trial Overview of Hospital Clinic de Barcelona
The University of Tokyo
Clinical Trial Overview of The University of Tokyo
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
List of Tables
Hepatitis C Therapeutics Market, Global, Clinical Trials by Zone, 2011-
Hepatitis C Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Hepatitis C Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011-
Hepatitis C Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2011-
Hepatitis C Therapeutics Clinical Trials, Europe, Top Five Countries, 2011-
Hepatitis C Therapeutics Clinical Trials, North America, Top Countries, 2011-
Hepatitis C Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2011-
Hepatitis C Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2011-
Hepatitis C Therapeutics Clinical Trials, BRIC Countries, 2011-
Hepatitis C Therapeutics Clinical Trials, G7 Countries, 2011-
Hepatitis C Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011-
Hepatitis C Therapeutics Clinical Trials, E7 Countries, 2011-
Hepatitis C Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011-
Hepatitis C Therapeutics Market, Global, Clinical Trials by Phase, 2011-
Hepatitis C Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011-
Hepatitis C Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Hepatitis C Therapeutics Market, Global, Suspended Clinical Trials, 2011-
Hepatitis C Therapeutics Market, Global, Withdrawn Clinical Trials, 2011-
Hepatitis C Therapeutics Market, Global, Terminated Clinical Trials, 2011-
Hepatitis C Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Hepatitis C Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Hepatitis C Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011-
Hepatitis C Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Vertex Pharmaceuticals Incorporated, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Idenix Pharmaceuticals, Inc., 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Tibotec Pharmaceuticals Ltd., 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmasset, Inc, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Tanabe Pharma Corporation, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Romark Laboratories, L.C., 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Hoffmann-La Roche Inc., 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Achillion Pharmaceuticals, Inc., 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Human Genome Sciences, Inc., 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by French National Agency for Research on AIDS and Viral Hepatitis, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaohsiung Medical University Chung-Ho Memorial Hospital, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Okayama University, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Henry Ford Health System, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Rockefeller University, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by McGill University Health Center, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Ziv Medical Center, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Cornell University, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Clinic de Barcelona, 2011-
Hepatitis C Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2011-
List of Figures
Hepatitis C Therapeutics Market, Global, Clinical Trials by Zone (%), 2011-
Hepatitis C Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Hepatitis C Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011-
Hepatitis C Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011-
Hepatitis C Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011-
Hepatitis C Therapeutics Clinical Trials, North America, Top Countries (%), 2011-
Hepatitis C Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2011-
Hepatitis C Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2011-
Hepatitis C Therapeutics Clinical Trials, BRIC Countries (%), 2011-
Hepatitis C Therapeutics Clinical Trials, G7 Countries (%), 2011-
Hepatitis C Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011-
Hepatitis C Therapeutics Clinical Trials, E7 Countries (%), 2011-
Hepatitis C Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011-
Hepatitis C Therapeutics Market, Global, Clinical Trials by Phase (%), 2011-
Hepatitis C Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011-
Hepatitis C Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Hepatitis C Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Hepatitis C Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Hepatitis C Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011-
Hepatitis C Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011-
GlobalData Methodology
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
